Differential replication of avian influenza H9N2 viruses in human alveolar epithelial A549 cells

Genetic characterization and phylogenetic analysis revealed that there are multiple lineages of H9N2 viruses isolated from various types of poultry including chickens, ducks, quail and pigeons. The H9N2 virus lineages found to be the most prevalent in poultry in southern China include the H9N2/G1-like lineage represented by A/Quail/Hong Kong/G1/97 (H9N2/G1) and the H9N2/Y280-like lineage represented by A/Duck/Hong Kong/Y280/97 (H9N2/Y280) and A/Chicken/Hong Kong/G9/97 (H9N2/G9) since 1997 [1]. These H9N2 lineages continued to disseminate in domestic poultry with the development of multiple reassortant subtypes from East Asia to the Middle East [2]. Additionally, avian-to-mammalian transmissions of H9N2 viruses were reported in Southeastern China [3].

H9N2 viruses have repeatedly infected humans albeit causing a mild disease [3‐5]. The low pathogenic H9N2 virus is widespread in poultry across Asia and Europe with ample opportunities for interaction with humans. It has caused infection in pigs (a putative mixing vessel for pandemic emergence) and causes severe disease in experimentally infected mice without prior adaptation [6]. The virus has an affinity for binding sialic acid receptors found on the human upper respiratory tract [7]. As past pandemics were not caused by highly pathogenic avian influenza viruses, the endemic of H9N2 viruses in poultry as well as their tropism for humans are at least as likely to cause the potential pandemic as the H5N1 virus, which is still the focus of attention [8]. Additionally, the H9N2/G1 viruses share six viral genes (viz. PB2, PB1, PA, NP, M and NS) with the lethal H5N1 viruses causing human disease in 1997 [1]. Furthermore, an H9N2 avian-human reassortant virus has been shown to have enhanced replication and efficient transmission in ferrets [9]. Thus H9N2 virus group is regarded by the World Health Organization as a potential pandemic candidate. Therefore we examined the replication characteristics of H9N2 virus lineages in the human lung epithelial cell line (A549) so that we may obtain an insight into the pathogenesis of H9N2 viruses in humans.

To examine the replication efficiency of the H9N2 virus in human cells, A549 cells were infected with H9N2/G1, H9N2/Y280 or H9N2/G9 at a multiplicity of infection (m.o.i.) of 0.01 [10‐12]. The culture supernatants were collected at 6 h, 24 h and 48 h post-infection and the viral titres were determined by tissue culture infectious dose (TCID₅₀) assays using Madin-Darby canine kidney (MDCK) cells. Their replication efficiencies were compared with the human influenza A/Hong Kong/54/98 virus (H1N1). As shown in Fig. 1A, the TCID₅₀ titre of H9N2/G1 viruses at 24 h and 48 h post-infection were 10^3.6 and 10^4.5 per 0.1 ml, respectively. Similar viral titres were observed in H1N1-infected cells at the corresponding time points. In contrast, both H9N2/Y280 and H9N2/G9 viruses exhibited poor replication competence in A549 cells (Fig 1A). Thus our results showed that H9N2/G1 viruses replicated as efficiently as H1N1 in the human lung epithelial A549 cells.

Next we examine the host-specific effects on the replication of H9N2 viruses, the leghorn male hepatoma chicken liver (LMH) cells were infected by H9N2 subtypes or H1N1 virus. We also infected embryonated chicken eggs with these viruses and their viral titres were determined by a hemagglutination assay. As shown in Fig. 1B and 1C, the three H9N2 viruses and H1N1 virus replicated to similar levels in LMH cells and embryonated chicken eggs. Furthermore, we found that all of the influenza viruses replicated well in MDCK cells (Fig. 1D). Hence, our results showed that all H9N2 subtypes tested replicated efficiently in MDCK, LMH cells and embryonated chicken eggs.

To delineate the mechanisms underlying the differences in replication of H9N2 subtypes, we investigated the infectivity, transcription and translation of different viruses in A549 cells. A549 cells were first infected by H9N2/G1, H9N2/Y280, H9N2/G9 or H1N1 at an m.o.i. of 2 and the expression of viral nucleoprotein (NP) and matrix protein (M1) in the infected cells was examined by using immunofluorescent staining and Western analysis, respectively. Positive staining of the NP protein was found in both H9N2-infected and H1N1-infected A549 cells at 24 h post-infection (Fig. 2A). Interestingly, strong M1 protein expression was observed in cells infected with H9N2/G1 at 8 h and 24 h post-infection by using antibody against M1 protein of influenza type A viruses but not those infected with H9N2/Y280 or H9N2/G9 virus (Fig 2B). To exclude the possibility of the specificity of the antibody, we compared the expression of M1 protein in A549 cells infected with H1N1 or H9N2/G1 virus. Results similar to the viral titres, there were no significant differences of M1 protein expression in these two viruses (Fig. 2C). Next, we measured the mRNA level of M1 protein and acid polymerase protein (PA) in virus-infected A549 cells at 3 h, 6 h and 24 h post-infection by using quantitative RT-PCR assay [11]. The coding regions of the respective viral genes in H9N2 and H1N1 viruses were amplified by the conserved gene-specific PCR primers. Both M1 and PA mRNA were detected at 3 h post-infection and their levels increased at 24 h post-infection in H9N2- or H1N1-infected cells (Fig. 3A, B). We found that there was no significant difference in the level of the viral mRNA in the cells infected by either virus subtypes. Taken together, our results showed that the virus entry of the examined H9N2 subtypes seems comparable but there is a difference in M1 protein expression in human lung epithelial A549 cells. However, the discrepancy of the mRNA synthesis and protein expression in A549 cells with H9N2/Y280 or H9N2/G9 infection remains to be investigated.

Since 1999, the H9N2 viruses have been intermittently isolated from patients manifesting influenza-like symptoms [3, 4] and these viruses pose a pandemic threat. However, the pathogenicity of the avian influenza H9N2 viruses remains to be investigated. Recent studies have shown that avian or human influenza viruses including H5N1, H7N1 and H1N1 can infect cells in the human lung epithelium [13, 14]. In addition, a previous report showed that avian H5N1 virus can replicate both in the upper and lower respiratory tract [15]. These findings imply that avian influenza virus other than H5N1 may have similar replicating ability in human cells and tissues.

In this report, we found that all three H9N2 lineages tested can infect different cell types including A549 cells, MDCK and LMH as evident by the detection of H9N2 viral protein NP in the infected cells and embryonated chicken eggs. Interestingly, only H9N2/G1 virus could produce a high titre of virus particles in A549 cells comparable to the H1N1 infection. These results suggested that the disease severity of H9N2/G1-infected patients may be associated with the replication ability of the virus in specific cell types. From our results, we showed that the viral growth efficiency may not be due to the difference of infectivity of the virus subtypes. Instead, we found that the translation of M1 protein is impaired in H9N2/Y280 and H9N2/G9. Previous reports have shown that M1 forms the major structural component of the virion and plays an important role in virus budding and assembly [16, 17]. However, the detailed mechanisms underlying the translational efficiency of H9N2/G1 virus and its differences from that of the less efficient H9N2/Y280 and H9N2/G9 viruses in A549 cells remain to be investigated. Enami et al. previously showed that the NS1 can stimulate the translation of the M1 protein [18]. As the NS1 of H9N2/G1 is highly conserved to the human pathogenic H5N1 virus which were found during 1997, it is possible that the NS1 of H9N2/G1 may lead to a high translational efficiency on M1 protein production in human host while the other H9N2 subtypes are unable to do so.

The genetic background of different H9N2 subtypes (Table 1) may contribute to the differences in their respective replication ability. In regard to the hemagglutinin (HA) gene, both H9N2/Y280 and H9N2/G9 viruses belong to the same HA sublineage of H9N2 viruses, while H9N2/G1 and H5N1/97 viruses belong to a different sublineage [19]. Moreover, H9N2/G1 and H5N1/97 viruses possess the similar replication complexes that are pathogenic in mice [19]. The H9N2/G1 viruses share six internal genes, including PB2 with the H5N1/97 viruses, while the H9N2/G9 lineage viruses share PB1 and PB2 genes. By contrast, the H9N2/Y280 virus does not have this share features in its viral genome [1]. It has been shown by other reports that the PB2 protein in H5N1 viruses contributes to the host adaptation and virus growth in humans [20, 21]. Furthermore, it has been demonstrated that H5N1/97 viruses replicate efficiently in primary alveolar epithelial cells and the viral titre of the infected cells is comparable to that of the human influenza H1N1 viruses [22]. However, it is notable that the internal gene complements of the current Z genotype H5N1 viruses are different to those of H5N1/97 and H9N2/G1 [23]. Thus, the adaptation of H5N1 to grow in human cells reflects its potential ability to cross the species restriction resulting in its occasional transmission from the avian hosts to human.

Since both of the H9N2 human isolates from 1999 and 2003 caused mild respiratory symptoms in infected patients, we postulate that there may be some common factors that lead to effective infection among those viruses. The HA, NA, NP genes of H9N2 viruses that have infected humans belonged to either H9N2/G1 or H9N2 Y280-like sub-lineages. Interestingly however, irrespective of the derivation of the HA and NA genes, the PB2, PB1 and M genes of these human isolates all belong to the H9N2/G1 sublineage. The PA genes of these viruses belong to either the H9N2/G1 or the contemporary Z genotype H5N1 viruses [4]. It is notable that the polymerase gene complex and the M gene of the viruses arise either from the H9N2/G1 - H5N1/97 sublineage or from the recent H5N1-Z genotype lineage associated with recent human H5N1 disease but not from the H9N2/Y280-sublineage. Since H9N2/G9 viruses which share the H9N2/G1-like PB1 and PB2 genes also fail to replicate in the human alveolar epithelial A549 cells, it would possibly implicate the need for all three polymerase gene segments and/or the M gene segment for efficient replication in human cells.

Infection of patients with avian influenza virus subtypes including H4N8, H6N1, and H10N7 is inefficient and this may be due to the inefficient virus replication competence in human cells [24]. Here, we demonstrated the differential replication of H9N2 virus subtypes in human lung epithelial cells. It provides a cellular model to investigate the mechanisms of replication of avian influenza viruses in humans, as well as the interaction of viral proteins with host factors, which may contribute to the pathogenesis of avian influenza virus.